The Truth About GLP-1 Medications: Weight Loss, Muscle Preservation & Long-Term Success

“Welcome to the Forge Fitness, Nutrition & Habit Podcast. I’m Michael Parker, founder of Forge Fitness and Nutrition Coaching, author of The 90-Day Habit Transformation, and recently certified as a GLP-1 Exercise Specialist through the National Exercise & Sports Trainers Association. Over the last twenty-five years, I’ve watched countless trends move through the fitness industry. Low-fat diets. Low-carb diets. Detoxes. Fat burners. Meal replacement shakes. Keto. Fasting. Wearable technology. Every few years, there seems to be a new development that captures public attention and promises to solve a problem that millions of people have struggled with for decades. Today, that conversation revolves around GLP-1 medications.

Whether you’re talking about Ozempic, Wegovy, Zepbound, Mounjaro, or other medications in this category, they have fundamentally changed the weight-loss landscape. Physicians are prescribing them in record numbers. People are asking for them. Social media is flooded with success stories, cautionary tales, before-and-after photos, and all the dire warnings and medical horror stories, along with the confusing opinions from people who often have very little understanding of how these medications actually work. Like a typical social media influencer who is only click farming and begging for attention so you buy whatever shitty product they are affiliated with or sponsored by while trying to pass themselves off as an expert. Anyhow.

As someone who has spent most of his professional life helping people improve their health through exercise, nutrition, and behavioral change, I think it’s important to have a balanced discussion about these drugs. The reality is that millions of people are taking them. Pretending they don’t exist or dismissing them outright isn’t helpful. At the same time, treating them as a miracle solution that eliminates the need for exercise, proper nutrition, and long-term habit development is equally misguided.

The goal of today’s discussion is to cut through the hype and examine what the science actually tells us, where these medications can be helpful, where they can create challenges, and why I believe coaching is more important than ever for individuals who choose to use them. In fact, Forge Fitness and Nutrition Coaching has developed a GLP-1 Support Assessment Calculator to help those of you who are using these medications to better understand your current status with the drug, project your hydration, fitness and nutritional needs to support your efforts. The calculator is available on forgept.com. Now, one of the first things we need to acknowledge is that these medications work. That may sound obvious, but it is worth emphasizing because much of the debate surrounding GLP-1 drugs has become ideological. Some people want to portray them as dangerous shortcuts. Others present them as a revolutionary answer to obesity. Neither perspective fully captures the reality. The evidence supporting their effectiveness for weight loss is substantial and this episode will also be transcribed into a blog post with references and other resource links at foregpt.com for those interested in learning more and reviewing my support studies that framed my position on these medications.

One of the landmark studies published in the New England Journal of Medicine examined semaglutide in adults with overweight and obesity. Researchers found that participants receiving semaglutide experienced an average weight reduction approaching fifteen percent of their body weight, which significantly exceeded what was observed in the placebo group. For many individuals, that level of weight loss is clinically meaningful and can lead to improvements in blood pressure, blood sugar control, mobility, and overall quality of life. More recently, research on tirzepatide demonstrated even greater weight-loss outcomes, with some participants achieving reductions exceeding twenty percent of body weight. These are numbers that would have been difficult to imagine from a pharmaceutical intervention only a decade ago. So let’s begin with an important point: these medications are not ineffective. They are not scams. They are not simply the latest fad. They represent a significant advancement in obesity treatment and metabolic medicine. However, effectiveness and completeness are not the same thing. Weight loss is only one variable in a much larger health equation. When most people think about losing weight, they picture body fat disappearing. They imagine a smaller waistline, looser clothing, and a lower number on the scale. What many people don’t realize is that the body does not exclusively burn fat during periods of weight loss. Weight reduction often involves a combination of fat loss, water loss, glycogen depletion, and lean tissue loss. This distinction matters because muscle is not merely decorative tissue.

Muscle serves as one of the body’s largest metabolic organs. It contributes to glucose regulation, insulin sensitivity, movement efficiency, balance, strength, and physical independence. It plays a critical role in how well we function throughout our lives. When someone loses significant amounts of muscle along with body fat, the scale may show success while important aspects of health move in the wrong direction. This is one of the concerns that deserves far more attention in the GLP-1 conversation. Many people are familiar with the dramatic weight-loss stories associated with these medications, but fewer are aware that lean mass losses can account for a meaningful percentage of total weight reduction. While some degree of lean tissue loss occurs during almost any weight-loss intervention, the amount that is preserved or lost can be heavily influenced by lifestyle choices.

Before we go any further, it’s worth asking a question that almost nobody seems to be talking about. Why are so many people suddenly requiring medications that mimic a hormone our bodies already produce naturally? GLP-1, which stands for glucagon-like peptide-1, is not something pharmaceutical companies invented. It is a hormone produced primarily in the intestines after we eat. Its job is to help regulate blood sugar, slow stomach emptying, increase feelings of fullness, and communicate with the brain that we’ve consumed enough food. In many ways, GLP-1 acts as one of the body’s natural appetite management systems. The interesting question is whether modern lifestyles may be reducing our natural GLP-1 response in the first place. Research suggests that obesity, insulin resistance, poor dietary quality, chronic overconsumption of highly processed foods, inadequate sleep, chronic stress, and physical inactivity can all impair various appetite-regulation pathways, including those involving GLP-1. In simple terms, many people are living in environments that constantly encourage overeating while simultaneously weakening some of the biological signals that help regulate hunger and satiety. Think about how different the modern food environment is compared to what humans evolved with. Today we’re surrounded by hyper-palatable foods engineered to be convenient, calorie dense, and difficult to stop eating. Many meals contain very little fiber, inadequate protein, and are consumed rapidly while distracted. Sleep deprivation has become normal. Stress levels remain elevated. Physical activity continues to decline.

All of those factors can influence the hormones that help regulate appetite. The good news is that while pharmaceutical GLP-1 medications can dramatically amplify this pathway, there are also evidence-based strategies that may help support your body’s natural GLP-1 production. One of the most effective is increasing dietary protein intake. Protein-rich meals consistently produce greater satiety and stimulate several hormones involved in appetite regulation, including GLP-1. Dietary fiber appears to have a similar effect. When fiber is fermented by beneficial gut bacteria, short-chain fatty acids are produced, which can stimulate GLP-1 release. This is one reason diets rich in fruits, vegetables, legumes, and whole grains are consistently associated with improved appetite regulation.

Regular exercise may also enhance GLP-1 activity and improve insulin sensitivity. While exercise isn’t a magic bullet for weight loss by itself, it improves many of the metabolic processes that help the body regulate energy balance more effectively. Sleep is another major factor. Numerous studies have shown that insufficient sleep alters hunger hormones, increases cravings, and impairs appetite control. Many people spend tremendous amounts of money searching for advanced weight-loss solutions while routinely getting five or six hours of sleep each night. Stress management matters as well. Chronic stress can influence eating behaviors, food choices, and the hormonal environment surrounding appetite regulation. While nobody can eliminate stress entirely, learning to manage it more effectively may improve overall metabolic health. Now, to be clear, I’m not suggesting that someone with obesity can simply eat more vegetables, get more sleep, and expect the same degree of weight loss that many people experience with medications like semaglutide or tirzepatide. The data clearly show these medications produce effects that often exceed what lifestyle changes alone can achieve. What I am saying is that understanding how natural GLP-1 functions helps us appreciate that these medications work best when combined with the very lifestyle behaviors that support the body’s own regulatory systems. The medication is not replacing healthy habits and strength training. Ideally, it’s creating an opportunity to reinforce them. One topic that deserves far more attention in the GLP-1 conversation is hydration.

Most people understand that these medications reduce appetite, but many don’t realize they can also indirectly reduce fluid intake. In my coaching experience, when people eat less frequently, they often drink less frequently as well. Meals serve as natural reminders to consume fluids throughout the day, and when those meals become smaller or less frequent, hydration can suffer without people even noticing it. This becomes particularly important because dehydration can contribute to several symptoms that many individuals mistakenly attribute solely to the medication itself. Fatigue, headaches, dizziness, reduced exercise performance, constipation, and difficulty concentrating can all be worsened by inadequate fluid intake. While these symptoms can have multiple causes, hydration status is often one of the first variables that should be evaluated.

From a physiological perspective, water plays a critical role in nearly every process related to health and performance. It supports blood volume, nutrient transport, digestion, temperature regulation, joint lubrication, and muscle function. When hydration levels decline, the body becomes less efficient at performing these tasks. For someone actively trying to lose weight, maintain muscle, and improve overall health, even mild dehydration can become an unnecessary obstacle. Hydration becomes even more important when exercise is part of the equation. One of the primary goals I have for clients taking GLP-1 medications is preserving lean muscle tissue through resistance training. However, exercise performance is heavily influenced by hydration status. Research has repeatedly shown that even relatively small reductions in body water can impair strength, endurance, recovery, and cognitive function. In practical terms, that means an individual who is under-hydrated may find workouts feel more difficult, recovery takes longer, and overall training quality begins to decline. Another issue that frequently emerges is constipation. Slower gastric emptying is one of the mechanisms through which GLP-1 medications help regulate appetite and blood sugar. While this contributes to their effectiveness, it can also increase the likelihood of gastrointestinal discomfort in some individuals. Adequate hydration, along with appropriate fiber intake and physical activity, becomes an important part of managing digestive health while taking these medications.

One of the simplest recommendations I make to clients is to become intentional about hydration rather than relying on thirst alone. Thirst is not always an accurate indicator, particularly in busy adults who are focused on work, family responsibilities, and daily obligations. Establishing regular hydration habits throughout the day is often far more effective than trying to catch up after symptoms appear. The irony is that many people spend tremendous amounts of time discussing advanced nutrition strategies, supplements, and medication protocols while overlooking one of the most fundamental components of health. Water may not be exciting, but it remains one of the most powerful performance-enhancing tools available. If you’re taking a GLP-1 medication and experiencing fatigue, headaches, digestive issues, or poor workout performance, hydration should be one of the first areas you evaluate before assuming the medication itself is entirely responsible.

Basically, exercise and proper nutrition become critical. Research consistently demonstrates that resistance training is one of the most effective strategies for preserving lean body mass during periods of caloric restriction. Similarly, adequate protein intake helps provide the building blocks necessary to maintain muscle tissue when body weight is decreasing. Unfortunately, many GLP-1 users face challenges in both areas. Because these medications reduce appetite, some individuals struggle to consume enough food to meet their nutritional requirements. I’ve worked with people who tell me they simply forget to eat. Others report feeling full after only a few bites. While this can certainly facilitate weight loss, it can also create situations in which protein intake falls far below optimal levels. Imagine trying to maintain a house while simultaneously cutting off the supply of construction materials needed for repairs. Eventually, the structure begins to deteriorate.

Muscle tissue responds in much the same way. This is one reason why I believe exercise professionals, dietitians, and qualified coaches have an increasingly important role to play. The medication may influence appetite and calorie intake, but someone still needs to help individuals navigate the practical realities of preserving strength, maintaining muscle, and supporting long-term health. Another issue that concerns me is the public’s tendency to confuse weight loss with behavior change. Over the years, I’ve coached people through countless transformations. Some have lost twenty pounds. Others have lost more than one hundred. The individuals who maintain their progress long term almost always share one characteristic: they changed the way they live. They learned how to navigate restaurants. They developed consistency with exercise. They improved their sleep habits. They became more aware of emotional eating patterns. They built routines that supported their goals.

In other words, they acquired skills. The challenge with any intervention that produces rapid results is that it can create the illusion that the underlying problem has been solved. If someone has spent decades using food to cope with stress, boredom, frustration, or anxiety, reducing appetite does not automatically address those behaviors. The emotional triggers may still exist. The environmental cues may still exist. The habits may still exist. This isn’t a criticism of the medication. It’s simply an acknowledgment that physiology and psychology are not the same thing. One influences hunger. The other influences decision-making. Long-term success requires attention to both.

This is where I often see a disconnect in social media discussions. Many influencers focus almost exclusively on the medication itself. They debate dosages, side effects, and weight-loss percentages. Meanwhile, some of the most important questions go unaddressed. Are people getting stronger? Are they preserving lean mass? Are they consuming adequate protein? Are they developing sustainable eating behaviors? Are they learning skills that will help them maintain their results five years from now? Those questions may not generate sensational headlines, but they are the questions that determine long-term outcomes. Another misconception I encounter is the belief that exercise becomes less important when someone starts a GLP-1 medication. In reality, I would argue the opposite. When weight loss is occurring rapidly, exercise becomes more important, not less.

Resistance training provides a stimulus that tells the body to retain muscle tissue. It reinforces movement quality. It supports bone health. It improves functional capacity. It helps maintain strength while body weight decreases. Cardiovascular exercise remains valuable as well. Improved cardiovascular fitness is associated with better health outcomes across numerous populations. However, if someone asks me where to place the greatest emphasis during significant weight loss, my answer is almost always strength training.

Not because aesthetics matter most, but because preserving physical capability matters. The ability to carry groceries, climb stairs, lift luggage, play with grandchildren, remain independent, and avoid falls later in life has tremendous value. Muscle contributes to all of those outcomes. This brings us to another important point. The ultimate goal should not be to become lighter. The goal should be to become healthier. Those objectives often overlap, but they are not identical. A smaller body does not automatically guarantee a healthier body. A lower scale weight does not automatically indicate improved physical function. Health is multidimensional. It includes strength, mobility, metabolic health, cardiovascular fitness, psychological well-being, and the ability to participate fully in life.

When I work with clients who are taking GLP-1 medications, my focus extends well beyond the number on the scale. I want to know whether they’re maintaining strength. I want to know whether their protein intake is adequate. I want to know whether they are developing habits that will remain useful regardless of whether they continue taking the medication in the future. Because eventually, every individual faces a fundamental question.

What happens next? For some people, these medications may become a long-term treatment strategy. For others, they may not. Regardless of the path chosen, long-term health still depends on the behaviors that occur between injections, prescriptions, and doctor’s appointments. It depends on what happens in the kitchen. It depends on what happens in the gym. It depends on the choices made during stressful weeks, busy seasons, vacations, holidays, and unexpected life events. The medication can support those efforts, but it cannot replace them. As someone who recently completed specialized training in this area, I believe the future of coaching will involve helping clients integrate medical interventions with evidence-based exercise, nutrition, and behavioral strategies. The most successful professionals in this field will not position themselves as blindly for or against GLP-1 medications. They will position themselves as knowledgeable guides who understand how to maximize benefits while minimizing risks.

That is the role I and the Forge Fitness and Nutrition Coaching team intend to play. If you are currently taking one of these medications, my advice is simple. Focus on preserving muscle. Prioritize resistance training. Make protein intake a priority. Pay attention to recovery. Develop habits that support your goals. Use the opportunity created by reduced appetite to build a healthier lifestyle rather than relying exclusively on the medication itself. GLP-1 medications may represent one of the most important developments in obesity treatment that we have seen in decades. They deserve serious discussion, thoughtful implementation, and ongoing research. At the same time, they should be viewed as tools rather than complete solutions. The people who experience the greatest success will likely be those who combine medical treatment with intelligent training, sound nutrition, and meaningful behavior change. That combination addresses not only the symptom of excess body weight, but also the broader lifestyle factors that contribute to long-term health. Thank you for joining me for today’s episode. If you found this discussion valuable, share it with someone who is currently taking a GLP-1 medication or considering one. And if you’re looking for professional guidance on how to preserve muscle, improve strength, and build sustainable habits while using these medications, visit ForgePT.com to learn more about our coaching services. I’m Michael S Parker, and I’ll see you next time.”

References

1. The Landmark Semaglutide (Wegovy) Weight-Loss Trial

Wilding JPH, et al. (2021).
“Once-Weekly Semaglutide in Adults with Overweight or Obesity.”
PubMed: https://pubmed.ncbi.nlm.nih.gov/33567185/

2. The Landmark Tirzepatide (Zepbound/Mounjaro) Trial

Jastreboff AM, et al. (2022).
“Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1).”
New England Journal of Medicine. PubMed: https://pubmed.ncbi.nlm.nih.gov/35658024/

3. Body Composition and Lean Mass Loss During GLP-1 Therapy

Neeland IJ, et al. (2024).
“Changes in Lean Body Mass with Glucagon-Like Peptide-1-Based Therapies and Mitigation Strategies.” DOI: 10.1111/dom.15728

4. GLP-1 Drugs, Muscle Mass, and Clinical Implications

Linge J, et al. (2024).
“Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists.”

5. Natural GLP-1 Production and Dietary Fiber

Tolhurst G, et al. (2012).
“Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein-Coupled Receptor FFAR2.” Diabetes. DOI: 10.2337/db11-1019

6. Protein Intake, Satiety, and Appetite Regulation

Leidy HJ, et al. (2015).
“The Role of Protein in Weight Loss and Maintenance.”
American Journal of Clinical Nutrition. DOI: 10.3945/ajcn.114.084038

7. Sleep and Appetite Regulation

Taheri S, et al. (2004).
“Short Sleep Duration Is Associated with Reduced Leptin, Elevated Ghrelin, and Increased Body Mass Index.” DOI: 10.1371/journal.pmed.0010062

8. Exercise, Metabolic Health, and Appetite Regulation

Donnelly JE, et al. (2009).
“Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults.”
American College of Sports Medicine Position Stand. DOI: 10.1249/MSS.0b013e3181949333